Medical Devices Startups

EarSmartAI is a medical software company that offers a system combining a mobile app, a connected otoscope, and AI algorithms to diagnose ear infections in young children. Aimed at parents of kids under age three, it captures eardrum video and analyzes symptoms to produce a likelihood score for ear infections.

1 investor

EarSwitch develops in-ear biometric control and sensor technologies for medical monitoring and healthcare applications, particularly supporting patients with neurological conditions. The company's in-ear devices enable device control and real-time health data recording, marketed toward healthcare providers and patients seeking non-intrusive monitoring solutions.

1 investor

EB Industries provides electron beam and laser beam welding services, offering technical expertise to help customers select the optimal welding process for their application requirements.

1 investor

EBVALLO is an on-demand allogeneic T-cell immunotherapy for treating relapsed or refractory EBV-positive post-transplant lymphoproliferative disease. The therapy uses anti-EBV-specific cytotoxic T-cells expanded from third-party donors and matched to patient HLA compatibility.

1 investor

ECG247 is a medically certified wearable heart sensor with two ECG channels for continuous, long-term monitoring of heart rhythm to detect arrhythmias, with recordings uploaded to secure cloud storage accessible to healthcare professionals via a portal and companion app. It is designed for both self-testing by patients and professional use in healthcare, and has been validated in clinical studies including NORSCREEN, HUNT, and the Tromsø study.

1 investor

Eclipse Regenesis develops a regenerative therapy platform for treating intestinal failure, starting with Short Bowel Syndrome, and extending to other complex gastrointestinal conditions. The company is a medical device developer focused on enabling the body's own tissue to rebuild rather than relying on invasive replacements.

1 investor

Ecodmlab develops electroceramic materials and manufactures beauty and medical devices using patented ultrasound technology for applications including HIFU, ultrasonic probes, sensors, and actuators. The company produces branded consumer and professional beauty devices alongside medical device offerings.

1 investor

Edgewood Oncology is a clinical-stage biotechnology company developing BTX-A51, a first-in-class treatment candidate for hematologic malignancies and genetically-defined solid tumors. The company focuses on addressing unmet medical needs in cancer treatment.

1 investor

Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.

1 investor

EDX Medical is a healthcare/medical services company led by experienced directors from the pharmaceutical, biotech, and medical sectors. The company appears to operate in the medical diagnostics and laboratory services space based on its team's expertise in laboratory management, pathology, and life sciences.

1 investor

EFI is a medical technology and device company developing haptic-feedback technology for laparoscopic minimally invasive surgery, using patented optical and strain-gauge sensors to give surgeons tactile and force feedback on tissue stiffness and arterial pulsations. Its instruments include the OptiGrip (undergoing CE certification) and the OptiTouch, and it is also developing robotic applications.

1 investor

Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products. It operates in the pharmaceutical industry focused on pain treatment.

1 investor

EGZOTech develops rehabilitation robots that provide personalized, adjustable therapy sessions, working with clinicians, physiotherapists, and rehabilitation therapists. The company serves healthcare providers and rehabilitation professionals worldwide.

1 investor

Eikonizo develops small molecule therapeutics targeting neurodegenerative and cardiorenal diseases. The company is focused on creating novel, disease-modifying treatments to improve patient outcomes.

1 investor

Eisai is a global research-based pharmaceutical company focused on neurology and oncology, with a commitment to patient-centric healthcare solutions worldwide.

1 investor

EKF Diagnostics is a global diagnostics and biotechnology company that develops and manufactures point-of-care medical devices, laboratory tests, and life sciences reagents for healthcare professionals and research applications. The company operates manufacturing facilities in the US and Germany and distributes products across over 120 countries.

1 investor

Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.

1 investor

Elcyo develops variable focus liquid crystal lenses and electronic eyewear devices to address vision problems and create comfortable extended reality (XR/VR/AR/MR) experiences. The company targets people with presbyopia, cataracts, low vision, and users seeking improved visual comfort in immersive technologies.

1 investor

Electrokare develops continuous biomarker monitoring and intelligence systems for athletes and patients with chronic conditions, using real-time chemistry analytics to inform performance optimization and clinical care decisions.

1 investor

ElectroPhysiology Frontiers is a MedTech company that develops a "single-shot" catheter ablation system for pulmonary vein isolation, aimed at creating more durable ablation lesions and reducing recurrence of atrial fibrillation (AFib). Its system incorporates a catheter-stabilizing anchor and a circumferential linear array of electrodes, serving cardiac electrophysiology and catheter ablation treatment of AFib patients.

1 investor

Eledon Pharmaceuticals is a clinical-stage biotechnology company developing immunology-based therapies, with a focus on protecting transplanted organs from rejection and treating autoimmune and neurodegenerative diseases including ALS. The company's lead candidate is tegoprubart, an anti-CD40L antibody.

1 investor

ELEM develops healthcare digital twins using biosimulation technology to enable pharmaceutical and medical device companies to test and predict treatment outcomes before clinical trials. The company combines biomedical science, mechanistic modeling, AI, and high-performance computing to replicate human physiology for safer, more efficient drug and device development.

1 investor

Element Materials Technology provides materials testing, product qualification, and assurance services for customers in aerospace, space, defense, and energy sectors. The company operates two global business lines and serves highly regulated industries.

1 investor

Jewel is a wearable patch cardioverter defibrillator designed to provide continuous protection from sudden cardiac arrest, using machine learning to minimize false alarms while requiring no daily maintenance for up to a week. The product targets patients who need cardiac protection, offering an alternative to traditional wearable devices with improved ease of use and compliance.

1 investor